baber/WOPTO huggingface dataset:
Patent AU-752383-B2 (AU)
Title: Pharmaceuticals comprising n,n'-bis(2- hydroxybenzyl) ethylenediamine-n, n'-diacetic acid for iron chelating therapy
Inventor: BERGERON RAYMOND J JR
IPC: A61K31/195
Filed: 1999-02-03
Granted: 2002-09-19
Abstract: The use of a novel mono-cationic salt of N,N'-bis(2-hydroxybenzyl)ethylenediamine-N,N'-diacetic acid (HBED) in iron chelating therapy is disclosed. In particular, the invention relates to the subcutaneous use of a mono cationic salt of HBED for treating a human with a disease treatable by an iron chelator such as iron overload, especially transfusional iron overload.
Patent AU-776777-B2 (AU)
Title: Process for the preparation of pyrazolopyridazine derivatives
Inventor: MATHEWS NEIL
IPC: C07C317/24
Filed: 2000-12-20
Granted: 2004-09-23
Abstract: A process for the preparation of a compound of formula (I)and pharmaceutically acceptable derivatives thereof in which:R<0 >is halogen, C1-6alkyl, C1-6alkoxy, C1-6alkoxy substituted by one or more fluorine atoms, or O(CH2)nNR<4>R<5>;R<1 >and R<2 >are independently selected from H, C1-6alkyl, C1-6alkyl substituted by one or more fluorine atoms, C1-6alkoxy, C1-6hydroxyalkyl, SC1-6alkyl, C(O)H, C(O)C1-6alkyl, C1-6alkylsulphonyl, C1-6alkoxy substituted by one or more fluorine atoms, O(CH2)nCO2C1-6alkyl, O(CH2)nSC1-6alkyl, (CH2)nNR<4>R<5>, (CH2)nSC1-6alkyl or C(O)NR<4>R<5>; with the proviso that when R<0 >is at the 4-position and is halogen, at least one of R<1 >and R<2 >is C1-6alkylsulphonyl, C1-6alkoxy substituted by one or more fluorine atoms, O(CH2)nCO2C1-6alkyl, O(CH2)nSC1-6alkyl, (CH2)nNR<4>R<5 >or (CH2)nSC1-6alkyl, C(O)NR<4>R<5>;R<3 >is C1-6alkyl or NH2;R<4 >and R<5 >are independently selected from H, or C1-6alkyl or, together with the nitrogen atom to which they are attached, form a 4-8 membered saturated ring; andn is 1-4.
Patent AU-766741-B2 (AU)
Title: Water current turbine sleeve mounting
Inventor: FRANKEL PETER
IPC: F03B17/06
Filed: 2000-02-23
Granted: 2003-10-23
Abstract: A flowing water actuatable turbine system, wherein the turbine system is mounted for operational co-operation with water current by means of an upstanding column/pile in such manner as to be axially displaceable length ways of the column/pile. The turbine system is preferably arranged to be rotatably about the longitudinal axis of the column. Floatation means can be provided for operationally supporting the turbines which can include blade pitch control.
Patent AU-697860-B2 (AU)
Title: Thinned halftone dot patterns for inkjet printing
Inventor: RYLANDER RICHARD L
IPC: B41J2/21
Filed: 1995-07-05
Granted: 1998-10-22
Abstract: A set of thinned halftone dot patterns useful in inkjet printing comprises a plurality of halftone cells corresponding to respective shade values. Each of the halftone cells includes a plurality of addressable points, with at least some of the points being turned "on" to define a halftone dot pattern, and at least some of the "on" points defining a core component of the halftone dot pattern being selectively turned "off", thereby producing a thinned halftone dot pattern. The thinned halftone dot patterns enable the use of higher addressability in an inkjet printing system to achieve a wider range of shade values while avoiding undesirable over-inking of printed halftone dot patterns due to excessive overlap between printed ink spots. The thinned halftone dot patterns prevent significant overlap between adjacent ink spots in the core, or "interior", component when the halftone dot pattern is printed by the inkjet printing system, but preserves the entire edge component to maintain desired halftone cell definition. Thinned halftone cells can be stored in a memory as "glyphs" and retrieved by an inkjet printing system to print higher addressability halftone images with enhanced quality and a wider range of shade values.
Patent AU-617157-B2 (AU)
Title: Intravaginal delivery of biologically active polypeptides
Inventor: FUJII TAKERU
IPC: A61K38/095
Filed: 1989-03-13
Granted: 1991-11-21
Abstract: Pharmaceutical compositions of matter adapted for intravaginal administration comprise a biologically active polypeptide, an absorption promoter, such as an anionic and/or nonionic surfactant or a nonionic surfactant and an aliphatic carboxylic acid, optionally an animal and/or vegetable protein and a nontoxic pharmaceutically acceptable carrier or diluent therefor, in a formulation suitable for intravaginal administration. Preferred compositions comprise calcitonin as the biologically active polypeptide. Preferred absorption promoters are anionic surfactants, e.g., sodium lauryl sulfate, and the combination absorption promoter of a nonionic surfactant and a medium chain aliphatic carboxylic acid or its salt, e.g. polyoxyethylenealkylphenylether and a medium chain aliphatic carboxylic acid.
Patent AU-661097-B2 (AU)
Title: Process and apparatus for direct determination of low density lipoprotein
Inventor: LAW WAI TAK
IPC: C12Q1/60
Filed: 1992-12-11
Granted: 1995-07-13
Abstract: Low density lipoprotein are directly determined in body fluids by selectively precipitating very low density lipoprotein, forming clusters with low density lipoproteins, selectively consuming the high density lipoproteins, and resolubilizing the low density lipoproteins for direct determination thereof. The clusters are formed by treating the fluid sample with a mixture of a polyanionic compound, a divalent metal, and a nucleating agent.
Patent AU-666350-B2 (AU)
Title: A method and a sealing element for manufacturing sealing rings
Inventor: HALLSTEDT GORAN
IPC: F16L17/00
Filed: 1993-03-03
Granted: 1996-02-08
Abstract: A method for manufacturing at leat two different types of sealing rings, each sealing ring comprising at least two annular elements which are bound to each other and with regard their hardness are of different kinds. An annular element (1) of a first kind is manufactured with one and the same design irrespectively of the type of the sealing ring which is to be manufactured and is provided with at least two separate binding surfaces (20, 22) for binding to element or elements (34, 50) of the second kind. The element or elements (34, 50) of the second kind is or are manufactured with a design adapted with regard to the desired type of sealing ring and is or are bound to one of or each one of the binding surfaces (20, 22) provided at the element of the first kind. <IMAGE>
Patent AU-661559-B2 (AU)
Title: Process for recovering the overspray of aqueous coating agents during spray application in spray booths
Inventor: SAATWEBER DIETRICH DR
IPC: B05B14/462
Filed: 1993-03-09
Granted: 1995-07-27
Abstract: A method is described for recovering the overspray of water-based coating materials produced by spray coating in spray booths, in which water-based circulating liquid is circulated in order to take up the overspray. The overspray material is removed from the circulating liquid continuously or discontinuously in an electrocoagulation bath, the concentration of the overspray in the electrocoagulation bath being kept higher, by means of ultrafiltration, than in the circulating liquid of the spray booth. <IMAGE>
Patent AU-708080-B2 (AU)
Title: Process for producing recombinant proteins, plasmids and modified cells
Inventor: CAMERON BEATRICE
IPC: C12N15/68
Filed: 1995-09-14
Granted: 1999-07-29
Abstract: PCT No. PCT/FR95/01178 Sec. 371 Date Mar. 12, 1997 Sec. 102(e) Date Mar. 12, 1997 PCT Filed Sep. 14, 1995 PCT Pub. No. WO96/08572 PCT Pub. Date Mar. 21, 1996Expression plasmids comprising a nucleic acid sequence of interest controlled by a T7 bacteriophage promoter and a stabilizing region comprising all or part of the par region of the RP4 plasmid or a derivative thereof. The invention also concerns the use of said plasmids in the production of recombinant products.
Patent AU-715149-B2 (AU)
Title: Process for the production of enantiomerically enriched (N)-acylazetidine-2-carboxylic acids
Inventor: POTTER GERARD ANDREW
IPC: C07D205/08
Filed: 1997-07-15
Granted: 2000-01-20
Abstract: PCT No. PCT/GB97/01915 Sec. 371 Date Dec. 16, 1998 Sec. 102(e) Date Dec. 16, 1998 PCT Filed Jul. 15, 1997 PCT Pub. No. WO98/02417 PCT Pub. Date Jan. 22, 1998Process for obtaining an enantiomerically enriched N-acylazetine-2-carboxylic acid by selectine crystallization of a diastereoisomeric salt formed by relcting an enantiomer of the N-acylazetidine-2-carboxylic acid and an enantiomer of 1-phenylethylamine.
Patent AU-701712-B2 (AU)
Title: Proof-of-entry device and badge suitable in particular for such a device
Inventor: CHMIEL JEHOSHUA
IPC: G09F3/20
Filed: 1995-09-08
Granted: 1999-02-04
Abstract: A proof-of-use device made of a thick fibrous sheet such as paperboard has manually tearable perforation defining an invalidation component on one side of the perforation and a basic component on the other side of the perforated region. The basic component has a front surface adaptable to receiving a badge image. A flexible region formed in the basic component defines a hinge along which the basic component is bendable over on itself. An attaching component is applied to at least one selected region of the basic component. Depending on configuration the attaching component may be on the front or back of the basic component. The attaching component and the hinge make the basic component attachable for wearing to display the badge image.
Patent AU-587169-B2 (AU)
Title: Motion-detection system
Inventor: PARSONS NATAN E
IPC: F16K31/04
Filed: 1984-11-30
Granted: 1989-08-10
Abstract: A control circuit (16) mounted on a faucet (10) operates an ultrasonic transducer (20) that transmits ultrasound into a target region (22) below the outlet (24) of the faucet. The control circuit receives electrical signals from the transducer when the transducer receives echoes from objects within the target region. The control circuit times the echoes to determine the distance of the object causing the echoes, and, if the distance of the object changes between successive measurements, the control circuit operates a valve (12) having an actuator that requires power only to change state so that it keeps the valve open when no power is applied. The circuit is powered by a rechargeable battery (18) that is charged by the action of a generator (31) that is driven by a turbine (34) powered by the flow of water through the faucet.
Patent AU-692930-B2 (AU)
Title: Dihalopropene compounds, insecticidal/acaricidal agents containing same, and intermediates for their production
Inventor: SAKAMOTO NORIYASU
IPC: A01P7/04
Filed: 1995-10-12
Granted: 1998-06-18
Abstract: The dihalopropene compounds of the general formula (I) have excellent insecticidal/acaricidal activity, so that they are satisfactorily effective for the control of noxious insects, mites and ticks.
Patent AU-754271-B2 (AU)
Title: Reagent and method for the permeabilization and identification of erythrocytes
Inventor: AGTHOVEN ANDRE VAN
IPC: G01N33/53
Filed: 1999-07-08
Granted: 2002-11-07
Abstract: A process for the permeabilization of erythrocytes is new and comprises successively subjecting the erythrocytes to: (a) a fixation agent comprising an aliphatic aldehyde and an oligosaccharide; (b) a permeabilization agent comprising a detergent and an oligosaccharide. Independent claims are also included for the following: (1) a kit (I) for the permeabilization of erythrocytes comprising: (a) an isotonic or hypertonic fixation agent comprising an aliphatic aldehyde and an oligosaccharide; (b) a permeabilization agent comprising a detergent and an oligosaccharide; (2) a kit for immunolabeling fetal erythrocytes comprising a permeabilization kit (I) and two antibodies against two fetal antigens that are independently expressed on the erythrocyte; and (3) a process for identifying fetal erythrocytes by immunolabeling, comprising successively subjecting erythrocytes to: (i) a fixation agent comprising an aliphatic aldehyde and an oligosaccharide in an isotonic or hypertonic medium; (ii) a permeabilization agent comprising a detergent and an oligosaccharide; (iii) a washing agent for eliminating the detergent; and (iv) two antibodies against two fetal antigens that are independently expressed on the erythrocyte followed by the detection of fetal erythrocytes.
Patent AU-700542-B2 (AU)
Title: Method and apparatus for sewage water treatment
Inventor: TOPOL JAN
IPC: C02F3/00
Filed: 1995-12-04
Granted: 1999-01-07
Abstract: PCT No. PCT/CZ95/00027 Sec. 371 Date May 27, 1997 Sec. 102(e) Date May 27, 1997 PCT Filed Dec. 4, 1995 PCT Pub. No. WO96/16908 PCT Pub. Date Jun. 6, 1996Method for sewage water treatment using suspended activated sludge where sewage water is supplied to the equalizing tank being then re-pumped to the activation tank from which is supplied to the post-sedimentation tank after the clearing process and from here, after the remaining sludge sedimentation, to the drainage. The activation process is automatically interrupted after a drop of the sewage water level in the equalizing tank below the minimum level setting and the excessive sludge is then pumped off from the activation tank. The sludge re-pumping is interrupted and the activation process restored owing to the subsequent raising of the sewage water level in excess of the operation level setting.
Patent AU-700778-B2 (AU)
Title: Method and equipment for the production of shaft information data of a lift shaft
Inventor: GERSTENKORN BERNHARD
IPC: B66B1/34
Filed: 1996-01-18
Granted: 1999-01-14
Abstract: The method provides information on an elevator hoistway (1) to control an elevator. An elevator car (6) is provided to be guided in the hoistway. A readable code (3) is arranged in the hoistway. The code is read as an image. At least one pattern in the image of the code is detected. The detected pattern is compared to a reference pattern. Hoistway information is generated from the detected pattern to control the elevator. The appts. includes at least one sensor (10) to read the code. It also includes at least one device to detect the pattern. At least one computing unit evaluates the hoistway information contained in the pattern. Preferably the pattern detected includes at least one light region and one dark region. A pattern repetition distance is then derived from the spacing between the middle of dark regions. The position of the elevator car (6) is read from the repetition distance.
Patent AU-584898-B2 (AU)
Title: Cephalosporin derivatives
Inventor: BRADBURY ROBERT HUGH
IPC: C07D498/04
Filed: 1985-05-16
Granted: 1989-06-08
Abstract: (<sub>57</sub>) A cephalosporin derivative of the formula I:in which X is S, O, CH<sub>2</sub> or SO,represents one of C-7 acyl groups known in the cephalos porin art, R3 is hydrogen or methoxy, R4 is hydrogen, optionally substituted alkyl or allyl, and R5 is an aromatic heterocyclic ring system which is linked via carbon, and which contains a quaternised nitrogen atom.
Patent AU-667925-B2 (AU)
Title: Cryptographic data security in a secured computer system
Inventor: BOEBERT WILLIAM E
IPC: G06F21/31
Filed: 1993-04-15
Granted: 1996-04-18
Abstract: A data communication system providing for the secure transfer and sharing of data via a local area network and/or a wide area network. The system includes a secure processing unit which communicates with a personal keying device and a crypto media controller attached to a user's workstation. The communication between these processing elements generates a variety of data elements including keys, identifiers and attributes. The data elements are used to identify and authenticate the user, assign user security access rights and privileges, and assign media and device attributes to a data access device according to a predefined security policy. The data elements are manipulated, combined, protected and distributed through the network to the appropriate data access devices, which prevents the user from obtaining unauthorized data. <IMAGE>
Patent AU-606311-B2 (AU)
Title: Process for the preparation of very high purity sorbitol syrups
Inventor: DEVOS FRANCIS
IPC: C07C31/26
Filed: 1985-06-28
Granted: 1991-02-07
Abstract: 1. Process for the preparation of very high purity sorbitol syrup, characterized by the fact that a starting material of which a first part is constituted by a starch hydrolysate, is subjected to a process comprising in combination - a catalytic hydrogenation step of the starting material, - a chromatographic separation step of the starting material which has undergone hydrogenation into a first fraction containing very pure sorbitol which is recovered and into a second fraction containing, besides sorbitol, non-hydrogenated sugars as well as hydrogenated di- and polysaccharides, - an acid hydrolysis step of the abovesaid second fraction, which provides a partially hydrogenated starch hydrolysate which is recirculated and which constitutes a second part of the starting material subjected to the hydrogenation step.
Patent AU-773737-B2 (AU)
Title: Method of communications and communication network intrusion protection methods and intrusion attempt detection system
Inventor: SHEYMOV VICTOR I
IPC: G06F21/55
Filed: 2000-05-15
Granted: 2004-06-03
Abstract: The intrusion protection method and system for a communication network provides address agility wherein the cyber coordinates of a target host (14) are changed both on a determined time schedule and when an intrusion attempt is detected. The system includes a managment unit (18) which generates a random sequence of cyber coordinates and maintains a series of tables containing the current and next set of cyber coordinates. These cyber coordinates are distributed to authorized users (12) under an encryption process to prevent unauthorized access.
Patent AU-627540-B2 (AU)
Title: Drug for the treatment or prevention by passive immunization, of the hiv-infection and process for preparation thereof
Inventor: GRANDGEORGE MICHEL
IPC: A61K39/42
Filed: 1989-12-15
Granted: 1992-08-27
Abstract: Drug for the treatment or prevention by passive immunization of the HIV-infection and processes for preparation thereof. According to the invention, the drug consists of, or comprises, a preparation of anti-HIV gammaglobulins Ig6 and/or IgM of human origin without antibodies directed against glycoproteins of the HIV virus envelope and/or anti-CD4 antibodies.
Patent AU-624901-B2 (AU)
Title: Bead-like expandable molding materials having high heat distortion resistance and their preparation
Inventor: HAHN KLAUS
IPC: C08L25/04
Filed: 1990-02-13
Granted: 1992-06-25
Abstract: Bead-form expandable moulding compositions of high heat resistance contain from 80 to 99 % by weight of a styrene polymer, from 1 to 20 % by weight of poly(2,6-dimethyl)-1,4-diphenyl ether, from 3 to 10 % by weight of a C3-C6-hydrocarbon as blowing agent and optionally conventional additives. They are obtained by suspension polymerisation of a solution of the polyphenylene ether in styrene.
Patent AU-581488-B2 (AU)
Title: Production of pig iron from prereduced iron ore in a cyclone furnace
Inventor: PAPST GERO
IPC: C21B13/14
Filed: 1986-01-16
Granted: 1989-02-23
Abstract: A process for the production of pig iron from fine ore is described, in which initially the fine ore undergoes prereduction to a degree of metallization of preferably 65 to 75%. The sponge iron obtained is then melted down and under goes a final reduction. This process takes place in a melting cyclone 2, to which the sponge iron is supplied by means of a central opening 1 and into which are tangetially blown via a lateral opening 3 a carbon carrier, an oxygen-containing gas and optionally fluxes. As a result of the angular momentum produced, the sponge iron particles are deflected to the side and melted and finally reduced by the combustion gases of the carbon carrier. The molten iron collects in an iron bath 8. The gas produced in the melting cyclone is cooled from approximately 1500 DEG  C. to approximately 800 DEG  C. in a waste heat system 10, as well as by admixing cooling gas supplied via a line 11 and is then used for the prereduction of the iron ore.
Patent AU-640139-B2 (AU)
Title: Use of gestodene for the production of pharmaceutical agents
IPC: A61K45/06
Filed: 1990-05-17
Granted: 1993-08-19
Abstract: Steroids having a 15,16-double bond, especially gestodene (17 alpha -ethynyl-17 beta -hydroxy-18-methyl-4,15-estradien-3-one), can be used for the treatment of carcinomas that can be inhibited in their growth by the protein TGF beta  (Tumor Growth Factor  beta ), especially breast carcinoma. At least one antiestrogen can be coadministered.
Patent AU-728051-B2 (AU)
Title: Aryl or heteroaryl substituted 3,4-dihydroanthracene and aryl or heteroaryl substituted benzo{1,2-g}-chrom-3-ene, benzo{1,2-g}-thiochrom-3-ene and benzo{1,2-g}-1,2-dihydroquinoline derivatives having retinoid antagonist or retinoid inverse agonist type biological activity
Inventor: VULIGONDA VIDYASAGAR
IPC: C07D417/02
Filed: 1997-12-09
Granted: 2001-01-04
Abstract: Disclosed herein are compounds of the formula wherein R<SUB>1 </SUB>is independently H or alkyl of 1 to 6 carbons; R<SUB>2 </SUB>is optional and is defined as lower alkyl of 1 to 6 carbons, F, Cl, Br, I, CF<SUB>3</SUB>, fluoro substituted alkyl of 1 to 6 carbons, OH, SH, alkoxy of 1 to 6 carbons, or alkylthio of 1 to 6 carbons; n is an integer of between 0 and 2; o is an integer between 0 and 3; R<SUB>3 </SUB>is hydrogen, lower alkyl of 1 to 6 carbons, F, Cl, Br or I; R<SUB>4 </SUB>is heteroaryl or (R<SUB>5</SUB>)<SUB>p</SUB>-heteroaryl where the heteroaryl group is 5-membered or 6-membered and has 1 to 3 heteroatoms selected from the group consisting of O, S, and N; p is an integer having the values of 0-5; R<SUB>5 </SUB>is F, Cl, Br, I, NO<SUB>2</SUB>, N(R<SUB>8</SUB>)<SUB>2</SUB>, N(R<SUB>8</SUB>)CORO<SUB>8</SUB>, N(R<SUB>8</SUB>)CON(R<SUB>8</SUB>)<SUB>2</SUB>, OH, OCOR<SUB>8</SUB>, OR<SUB>8</SUB>, CN, COOH, COOR<SUB>8</SUB>, C<SUB>1-10 </SUB>alkyl, fluoro substituted C<SUB>1-10 </SUB>alkyl, C<SUB>2-10 </SUB>alkenyl having 1 to 3 double bonds, C<SUB>2-10 </SUB>alkynyl having 1 to 3 triple bonds, or a (trialkyl)silyl or (trialkyl)silyloxy group where the alkyl groups independently have 1 to 6 carbons; A is (CH<SUB>2</SUB>)<SUB>q </SUB>where q is 0-5, C<SUB>3-6 </SUB>branched alkyl, C<SUB>3-6 </SUB>cycloalkyl, C<SUB>2-6 </SUB>alkenyl having 1 or 2 double bonds, or C<SUB>2-6 </SUB>alkynyl having 1 or 2 triple bonds; B is hydrogen, COOH or a pharmaceutically acceptable salt thereof, COORO<SUB>8</SUB>, CONR<SUB>9</SUB>R<SUB>10</SUB>, CH<SUB>2</SUB>OH, CH<SUB>2</SUB>OR<SUB>11</SUB>, CH<SUB>2</SUB>OCOR<SUB>11</SUB>, CHO, CH(OR<SUB>12</SUB>)<SUB>2</SUB>, CHOR<SUB>13</SUB>O, COR<SUB>7</SUB>, CR<SUB>7</SUB>(OR<SUB>12</SUB>)<SUB>2</SUB>, CR<SUB>7</SUB>OR<SUB>13</SUB>O, or Si(C<SUB>1-6</SUB>alkyl)3; R<SUB>7 </SUB>is C<SUB>1-5 </SUB>alkyl, C<SUB>3-5 </SUB>cycloalkyl, or C<SUB>2-5 </SUB>alkenyl; R<SUB>8 </SUB>is C<SUB>1-10 </SUB>alkyl, C<SUB>1-10 </SUB>(trimethylsilyl)alkyl, or C<SUB>5-10 </SUB>cycloalkyl; R<SUB>9 </SUB>and R<SUB>10 </SUB>are independently hydrogen, C<SUB>1-10 </SUB>alkyl, C<SUB>5-10 </SUB>cycloalkyl, phenyl or R<SUB>12</SUB>-phenyl; R<SUB>11 </SUB>is C<SUB>1-6 </SUB>alkyl, phenyl, or R<SUB>12</SUB>-phenyl; R<SUB>12 </SUB>is C<SUB>1-6 </SUB>alkyl; and R<SUB>13 </SUB>is divalent alkyl radical of 2-5 carbons.
Patent AU-583126-B2 (AU)
Title: Pressure-resistant mixer
Inventor: EIRICH PAUL
IPC: B01F29/83
Filed: 1986-06-06
Granted: 1989-04-20
Abstract: Described is a pressure-resistant mixer with a feed opening (15), a rotating mixing container (1) with a drainage device (20) and with mixing tools (17) arranged eccentrically to the axis of the mixing container axis (35) inside the mixing container (1), and with drive motors (6, 22) and drive devices (33, 34) for driving the mixing devices (17) and/or the mixing container (1). In order, on the one hand, to avoid sliding seals in contact with the materials being mixed, and, on the other, to avoid having to use extremely large size seals, is proposed in accordance with the invention to position the mixing container (1) inside a stationary pressure vessel (3).